Sugary drinks and alcohol are getting relatively cheaper, the World Health Organization said yesterday, urging countries to ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Mental trauma, including specific phobias and posttraumatic stress disorder (PTSD), follows one in seven dog-related injuries ...

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...

The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...

Arkansas state laws that create an income tax credit for businesses that relocate their corporate headquarters in Arkansas ...

The U.S. Food and Drug Administration (FDA) has approved its first oral glucagon-like peptide (GLP)-1 pill for weight management, a news release from Novo Nordisk announced on Monday. The pill, Wegovy ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The prevalence of obesity is rising in veterans with ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

The guideline is based on the recognition of obesity as a chronic, relapsing disease that requires lifetime care. The World Health Organization (WHO) has released an evidence-informed guideline on the ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...